Checkpoint Blockade, Escape and Beyond in Cancer Immune Modulation

Immune checkpoint pathways play a central role in regulating T-cell activity, with PD-1 emerging as one of the most important targets in immunology and cancer research. Functional antibodies that modulate the PD-1 pathway are essential tools for studying immune regulation, modeling checkpoint blockade, and advancing immunotherapy development.

Watch this webinar with Dr. Gordon Freeman to explore how researchers use PD-1 blockade antibodies to investigate T-cell exhaustion, interrogate immune checkpoint signaling, study cancer and inflammatory disease models, and translate mechanistic discoveries into next-generation immunotherapy strategies.